New hope for anemic kids with kidney disease: drug trial shows promise
NCT ID NCT05682326
First seen Nov 11, 2025 · Last updated May 08, 2026 · Updated 31 times
Summary
This study tested a drug called daprodustat in children aged 3 months to 18 years who have anemia (low red blood cells) due to chronic kidney disease. The goal was to check how the drug works in the body, its safety, and its effect on hemoglobin levels over 52 weeks. Four children took part, some on dialysis and some not.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Aichi, 466-8650, Japan
-
GSK Investigational Site
Saitama, 330-8777, Japan
-
GSK Investigational Site
Tokyo, 162-8666, Japan
-
GSK Investigational Site
Yangsan, 50612, South Korea
Conditions
Explore the condition pages connected to this study.